日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Glands of Moll: history, current knowledge and their role in ocular surface homeostasis and disease

莫尔氏腺：历史、现状及其在眼表稳态和疾病中的作用

期刊:Progress in Retinal and Eye Research
影响因子:14.7
doi:10.1016/j.preteyeres.2025.101362
Stopfer, Michael; Zahn, Ingrid; Jüngert, Katharina; Aumüller, Gerhard; Moll, Frans L; Schicht, Martin; Makarenkova, Helen P; de Paiva, Cintia S; Paulsen, Friedrich P
发表日期：2025
文献求助 收藏

Corrigendum to "Glands of Moll: history, current knowledge and their role in ocular surface homeostasis and disease" [Progr. Retin. Eye Res. 106 (2025) 101362]

对“Moll腺：历史、当前知识及其在眼表稳态和疾病中的作用”的更正[Progr. Retin. Eye Res. 106 (2025) 101362]

期刊:Progress in Retinal and Eye Research
影响因子:14.7
doi:10.1016/j.preteyeres.2025.101364
Stopfer, Michael; Zahn, Ingrid; Jüngert, Katharina; Aumüller, Gerhard; Moll, Frans L; Schicht, Martin; Makarenkova, Helen P; de Paiva, Cintia S; Paulsen, Friedrich P
发表日期：2025
文献求助 收藏

Process Development of a Model Solvate for Drying Research

用于干燥研究的模型溶剂化物工艺开发

期刊:Organic Process Research & Development
影响因子:3.5
doi:10.1021/acs.oprd.5c00095
McCarthy, Nicholas H; Alsaiari, Norah S; Brown, Thomas; Mahdi, Faiz M; Bayly, Andrew E; Finn, Sadie; Muller, Frans L
发表日期：2025
文献求助 收藏

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B)

奥拉帕尼药代动力学增强：一项多中心、开放标签、随机、非劣效性试验的研究方案（PROACTIVE-B）

期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2025.101477
Overbeek, Joanneke K; Guchelaar, Niels A D; Mohmaed Ali, Ma Ida; Sark, Muriëlle; Hovenier, Carolien; Kievit, Wietske; Ligtenberg, Marjolijn J L; Ottevanger, Petronella B; Bloemendal, Haiko J; Koolen, Stijn L W; Mathijssen, Ron H J; Boere, Ingrid A; Huitema, Alwin D R; Sonke, Gabe S; Opdam, Frans L; Ter Heine, Rob; van Erp, Nielka P
发表日期：2025
文献求助 收藏

Automated Optimization of a Multistep, Multiphase Continuous Flow Process for Pharmaceutical Synthesis

用于药物合成的多步多相连续流工艺的自动化优化

期刊:ACS Sustainable Chemistry & Engineering
影响因子:7.3
doi:10.1021/acssuschemeng.4c05015
Boyall, Sarah L; Clarke, Holly; Dixon, Thomas; Davidson, Robert W M; Leslie, Kevin; Clemens, Graeme; Muller, Frans L; Clayton, Adam D; Bourne, Richard A; Chamberlain, Thomas W
发表日期：2024
文献求助 收藏

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

BMI对HR+/HER2-晚期乳腺癌患者预后的影响：一项基于SONABRE注册研究的分析

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-07108-6
Lammers, Senna W M; Thurisch, Hannah; Vriens, Ingeborg J H; Meegdes, Marissa; Engelen, Sanne M E; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Peters, Natascha A J B; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Teeuwen, Nathalie J A; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review

微剂量法在细胞色素P450酶体内表型分析中的应用：现状如何？综述

期刊:European Journal of Drug Metabolism and Pharmacokinetics
影响因子:2.4
doi:10.1007/s13318-024-00896-2
van der Heijden, Lisa T; Opdam, Frans L; Beijnen, Jos H; Huitema, Alwin D R
细胞生物学
发表日期：2024
文献求助 收藏

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

首次人体 I 期研究，评估 OX40 激动剂 GSK3174998 与或不与帕博利珠单抗联合治疗特定晚期实体瘤患者的疗效 (ENGAGE-1)

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005301
Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Rahma, Osama; Paul, Elaine M; Ahlers, Christoph M; Zhou, Helen; Struemper, Herbert; Gorman, Shelby A; Watmuff, Maura; Yablonski, Kaitlin M; Yanamandra, Niranjan; Chisamore, Michael J; Schmidt, Emmett V; Hoos, Axel; Marabelle, Aurelien; Weber, Jeffrey S; Heymach, John V
ENG
GSK3
发表日期：2023
文献求助 收藏

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial

绝经后乳腺癌患者序贯内分泌治疗后延长辅助芳香化酶抑制治疗：随机3期DATA试验的随访分析

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.101901
Tjan-Heijnen, Vivianne C G; Lammers, Senna W M; Geurts, Sandra M E; Vriens, Ingeborg J H; Swinkels, Astrid C P; Smorenburg, Carolien H; van der Sangen, Maurice J C; Kroep, Judith R; de Graaf, Hiltje; Honkoop, Aafke H; Erdkamp, Frans L G; de Roos, Wilfred K; Linn, Sabine C; Imholz, Alexander L T
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions

除了皮疹之外：阿培利西布诱发的过敏反应

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad092
Schutte, Tim; Zeverijn, Laurien J; Geurts, Birgit S; de Wit, Gijsbrecht F; Kok, Marleen; Opdam, Frans L
发表日期：2023
文献求助 收藏